Stocks in Focus

International Oil Prices Plunge Following Ceasefire Agreement… Airline Stocks in Freefall [Featured Stocks]

Kim Kyung-eun
2026-06-15 09:25:31
[Edaily Reporter Kim Kyung-eun] As international oil prices plummeted following the ceasefire agreement between the U.S. and Iran, airline stocks are rallying in tandem.



According to MP Doctor on the 15th, as of 9:18 a.m. today, #JejuAir is trading at 5,580 won, up 1,240 won (28.57%) from the previous trading day.

At the same time, #T'way Holdings (24.37%), #Trinity Air (22.69%), #Jin Air (16.70%), #Air Busan (14.45%), #Asiana Airlines (9.62%), and #Korean Air (9.40%) are all on the rise.

This is interpreted as a result of the sharp drop in international oil prices following the end-of-war agreement between the U.S. and Iran. When oil prices fall, airlines’ fuel costs decrease, raising expectations for improved profitability.

U.S. President Donald Trump posted on the social media platform Truth Social around 5:30 p.m. Eastern Time on the 14th, stating, “An agreement with Iran has just been finalized.”

Reuters and AFP reported that Kazem Gharibabadi, Iran’s Deputy Foreign Minister, said in a TV interview that a “permanent and immediate ceasefire has been declared on all fronts, including Lebanon,” regarding the war with the U.S.

Brent crude, the global benchmark, fell 3.9% to $84 per barrel, while U.S. West Texas Intermediate (WTI) crude dropped 4.8% to trade at around $81 per barrel.

Economy

Corporation

IT·Science

Economy

"Why Should I Buy That Apartment for You?"... Will It Take 30 Years for Gen Z and Millennials to Buy a Home in Seoul?

(Photo: Blind) One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
2026-10-04 12:00:03

Corporation

GI Innovation and G2G Bio Jump 20% on Hopes for a Licensing Deal [K-bio pulse]

The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
2026-10-03 07:22:03

IT·Science

Roche’s Choice: HanmiPharm’s New Obesity Drug; Vice President Choi In-young: “We Wanted to Lose Fat and Gain Muscle”

Lose fat while preserving muscle. As Roche has discontinued emugrovat—a candidate it was developing to counteract muscle loss during obesity treatment—the role of “HM17321,” a technology licensed by H…
2026-10-05 07:16:02